{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T20:51:08Z","timestamp":1778100668616,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018812","name":"Instituto de Investigaci\u00f3n Marqu\u00e9s de Valdecilla","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018812","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.biopha.2025.118398","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T16:28:34Z","timestamp":1754324914000},"page":"118398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Inhibition of NEDDylation enhances the cytostatic effect of Rohinitib on chronic lymphocytic leukemia cells"],"prefix":"10.1016","volume":"190","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7670-5515","authenticated-orcid":false,"given":"Jose Luis","family":"Casta\u00f1o","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4548-6422","authenticated-orcid":false,"given":"V\u00edctor","family":"Arenas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Jos\u00e9","family":"Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9630-5893","authenticated-orcid":false,"given":"Sara","family":"Fern\u00e1ndez-Luis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucrecia","family":"Y\u00e1\u00f1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3851-6710","authenticated-orcid":false,"given":"Carlos","family":"Pipa\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118398_bib1","article-title":"Chronic lymphocytic leukaemia","volume":"3","author":"Kipps","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"7574","key":"10.1016\/j.biopha.2025.118398_bib2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature14666","article-title":"Non-coding recurrent mutations in chronic lymphocytic leukaemia","volume":"526","author":"Puente","year":"2015","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biopha.2025.118398_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12943-022-01496-x","article-title":"Overexpression of wild type RRAS2, without oncogenic mutations, drives chronic lymphocytic leukemia","volume":"21","author":"Hortal","year":"2022","journal-title":"Mol. Cancer"},{"issue":"19","key":"10.1016\/j.biopha.2025.118398_bib4","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1038\/s41388-022-02272-3","article-title":"Epigenetic regulation of EIF4A1 through DNA methylation and an oncogenic role of eIF4A1 through BRD2 signaling in prostate cancer","volume":"41","author":"Wang","year":"2022","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.biopha.2025.118398_bib5","doi-asserted-by":"crossref","first-page":"a012377","DOI":"10.1101\/cshperspect.a012377","article-title":"Emerging therapeutics targeting mRNA translation","volume":"4","author":"Malina","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"9","key":"10.1016\/j.biopha.2025.118398_bib6","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1038\/s41375-021-01308-z","article-title":"Inhibition of translation initiation factor eIF4a inactivates heat shock factor 1 (HSF1) and exerts anti-leukemia activity in AML","volume":"35","author":"Nishida","year":"2021","journal-title":"Leukemia"},{"issue":"17-18","key":"10.1016\/j.biopha.2025.118398_bib7","doi-asserted-by":"crossref","first-page":"6337","DOI":"10.1007\/s00018-021-03910-x","article-title":"Targeted inhibition of eIF4A suppresses B-cell receptor-induced translation and expression of MYC and MCL1 in chronic lymphocytic leukemia cells","volume":"78","author":"Wilmore","year":"2021","journal-title":"Cell Mol. Life Sci."},{"issue":"7516","key":"10.1016\/j.biopha.2025.118398_bib8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nature13485","article-title":"RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer","volume":"513","author":"Wolfe","year":"2014","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.biopha.2025.118398_bib9","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/cac2.12493","article-title":"Targeting mRNA translation aberrations: a novel approach for therapy in chronic lymphocytic leukemia","volume":"43","author":"Klapp","year":"2023","journal-title":"Cancer Commun"},{"issue":"13","key":"10.1016\/j.biopha.2025.118398_bib10","doi-asserted-by":"crossref","first-page":"21128","DOI":"10.18632\/oncotarget.15050","article-title":"Pevonedistat, a Nedd8-activating enzyme inhibitor, sensitizes neoplastic B-cells to death receptor-mediated apoptosis","volume":"8","author":"Paiva","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.biopha.2025.118398_bib11","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3390\/cancers17030533","article-title":"Distinct NF-kB regulation favors a synergic action of pevonedistat and laduviglusib in B-chronic lymphocytic leukemia cells ex vivo","volume":"17","author":"Arenas","year":"2025","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.biopha.2025.118398_bib12","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1038\/s41375-021-01184-7","article-title":"Map of ubiquitin-like post-translational modifications in chronic lymphocytic leukemia. Role of p53 lysine 120 NEDDylation","volume":"35","author":"Bravo-Navas","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.biopha.2025.118398_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.729550","article-title":"A different view for an old disease: NEDDylation and other Ubiquitin-Like Post-Translational modifications in chronic lymphocytic leukemia","volume":"11","author":"Arenas","year":"2021","journal-title":"Front. Oncol."},{"issue":"11","key":"10.1016\/j.biopha.2025.118398_bib14","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1111\/bcp.14078","article-title":"Population pharmacokinetics of pevonedistat alone or in combination with standard of care in patients with solid tumours or haematological malignancies","volume":"85","author":"Faessel","year":"2019","journal-title":"Br. J. Clin. Pharm."},{"issue":"W1","key":"10.1016\/j.biopha.2025.118398_bib15","doi-asserted-by":"crossref","first-page":"W739","DOI":"10.1093\/nar\/gkac382","article-title":"SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples","volume":"50","author":"Ianevski","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.biopha.2025.118398_bib16","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1182\/blood-2015-07-660969","article-title":"Engagement of the B-cell receptor of chronic lymphocytic leukemia cells drives global and MYC-specific mRNA translation","volume":"127","author":"Yeomans","year":"2016","journal-title":"Blood"},{"issue":"7239","key":"10.1016\/j.biopha.2025.118398_bib17","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/nature07884","article-title":"An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer","volume":"458","author":"Soucy","year":"2009","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biopha.2025.118398_bib18","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s43556-022-00112-0","article-title":"An overview of PROTACs: a promising drug discovery paradigm","volume":"3","author":"Liu","year":"2022","journal-title":"Mol. Biomed."},{"issue":"3","key":"10.1016\/j.biopha.2025.118398_bib19","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3390\/cancers17030557","article-title":"BTK is the target that keeps on giving: a review of BTK-Degrader drug development, clinical data, and future directions in CLL","volume":"17","author":"Salvaris","year":"2025","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.biopha.2025.118398_bib20","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1158\/2159-8290.CD-14-1040","article-title":"Targeting translation initiation bypasses signaling crosstalk mechanisms that maintain high MYC levels in colorectal cancer","volume":"5","author":"Wiegering","year":"2015","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.biopha.2025.118398_bib21","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13045-023-01485-7","article-title":"Targeting NEDD8-activating enzyme for cancer therapy: developments, clinical trials, challenges and future research directions","volume":"16","author":"Fu","year":"2023","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118398_bib22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41408-022-00763-w","article-title":"Pevonedistat, a Nedd8-activating enzyme inhibitor, in combination with ibrutinib in patients with relapsed\/refractory B-cell non-Hodgkin lymphoma","volume":"13","author":"Torka","year":"2023","journal-title":"Blood Cancer J."},{"issue":"24","key":"10.1016\/j.biopha.2025.118398_bib23","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.3390\/cancers15245817","article-title":"Mice overexpressing Wild-Type RRAS2 are a novel model for preclinical testing of anti-chronic lymphocytic leukemia therapies","volume":"15","author":"Hortal","year":"2023","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.biopha.2025.118398_bib24","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/embor.2008.10","article-title":"Ribosomal proteins are targets for the NEDD8 pathway","volume":"9","author":"Xirodimas","year":"2008","journal-title":"EMBO Rep."},{"issue":"6","key":"10.1016\/j.biopha.2025.118398_bib25","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1182\/blood.V82.6.1820.1820","article-title":"bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia","volume":"82","author":"Hanada","year":"1993","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.biopha.2025.118398_bib26","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.1182\/blood.V91.11.4342","article-title":"p53 expression in B-cell chronic lymphocytic leukemia: a marker of disease progression and poor prognosis","volume":"91","author":"Cordone","year":"1998","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.biopha.2025.118398_bib27","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.3109\/10428194.2014.990901","article-title":"Targeting neddylation effectively antagonizes nuclear factor-\u03baB in chronic lymphocytic leukemia B-cells","volume":"56","author":"Godbersen","year":"2015","journal-title":"Leuk. Lymphoma"},{"issue":"2","key":"10.1016\/j.biopha.2025.118398_bib28","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/sj.onc.1204067","article-title":"Negative regulation of bcl-2 expression by p53 in hematopoietic cells","volume":"20","author":"Wu","year":"2001","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.biopha.2025.118398_bib29","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cell.2004.06.016","article-title":"Mdm2-mediated NEDD8 conjugation of p53 inhibits its transcriptional activity","volume":"118","author":"Xirodimas","year":"2004","journal-title":"Cell"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222500592X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222500592X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T01:12:20Z","timestamp":1755738740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222500592X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":29,"alternative-id":["S075333222500592X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118398","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of NEDDylation enhances the cytostatic effect of Rohinitib on chronic lymphocytic leukemia cells","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118398","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118398"}}